Table 3.
Revised SELENA flare assessment and percent agreement with TPC flare assessment, and assessment excluding flare defined by treatment changea
| Assessment | No | Mild | Moderate | Severe | Total |
|---|---|---|---|---|---|
| Revised SELENA flare index | |||||
| No flare | 18 (58)b | 0 | 0 | 0 | 18 (12) |
| Mild flare | 4 (13) | 16 (44)b | 0 | 0 | 20 (13) |
| Moderate flare | 4 (13) | 19 (53) | 19 (63)b | 1 (2) | 43 (29) |
| Severe flare | 5 (16) | 1 (3) | 11 (37) | 52 (98)b | 69 (46) |
| Insufficient information | 0 | 0 | 0 | 0 | 0 |
| Total | 31 | 36 | 30 | 53 | 150 |
| Revised SELENA flare index without flare defined by treatment change | |||||
| No flare | 23 (74)b | 0 | 0 | 2 (4) | 25 (17) |
| Mild flare | 4 (13) | 25 (69)b | 5 (16.7) | 1 (2) | 35 (23) |
| Moderate flare | 3 (10) | 11 (31) | 23 (77)b | 3 (6) | 40 (27) |
| Severe flare | 1 (3) | 0 (0) | 2 (7) | 47 (89)b | 50 (33) |
| Insufficient information | 0 | 0 | 0 | 0 | 0 |
| Total | 31 | 36 | 30 | 53 | 150 |
a
Values are the number (%). SELENA = Safety of Estrogens in Lupus Erythematosus National Assessment; TPC = 3‐physician consensus.
b
Statistically significant.